The EPS projection of Ovascience Inc. (NASDAQ:OVAS) for quarter ended 2016-09-30 is $-0.84. Last week, the EPS forecast was $-0.84 against target of $-0.84, a month earlier. Two months ago, this estimate was $-0.84 versus forecast of $-0.84 three months earlier, implying a deviation of 0%.
Ovascience Inc. (NASDAQ:OVAS) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Ovascience Inc. (NASDAQ:OVAS) in the preceding 30, 120, 60 and 90 days were 0, 1, 1, and 1, correspondingly.
Ovascience Inc. (NASDAQ:OVAS) EPS target for the quarter closed 1 was $-0.84, based on 3 recommendations. As reported on 2016-05-05 the EPS was $-0.8. The change was $-0.05, implying a percentage deviation of -6.67%. The projections showed a standard deviation of 0.06.
Quarterly Sales Estimates
Ovascience Inc. (NASDAQ:OVAS) yearly sales prediction for the fiscal 2016 stands at $1.373 and the median estimate is at $1.8. Almost 3 analysts issued sales target.
Highest sales target is $2.12 while the lowest target is $0.2 showing standard deviation of 1.028%.
As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 0%.
Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast. Ovascience Inc. (NASDAQ:OVAS) announced that the deviation in forecast was -42.672%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...